Latest news with #www.KraigLabs.com
Associated Press
28-05-2025
- Business
- Associated Press
Kraig Biocraft Laboratories Announces New Spider Silk Parental Strain for Expanded Commercial Production
ANN ARBOR, Mich., May 28, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ('Company' or 'Kraig Labs'), a world leader in spider silk technology*, announces today the successful development of a new recombinant spider silk parental line, purpose-built for large-scale commercial production. This newly developed strain represents the third commercial production line created by Kraig Labs as it executes on its strategy to expand output capacity. The addition of this next-generation silk-producing line comes as the Company ramps up production to fulfill current material requests and strategically build inventory for future sales. 'Our team continues to deliver on key milestones as we scale the commercialization of spider silk,' said Company Founder and CEO, Kim Thompson. 'With the development of this new production strain, we are not only increasing our ability to meet existing demand, but also reinforcing the foundation for our future growth. This new strain is part of the production roadmap we outlined in 2024 and a key part of our transition to a full double hybrid production system.' This latest strain is part of Kraig Labs' broader development pipeline, which includes several additional parental lines currently in advanced stages of development. These lines are designed to enable a transition to a double hybrid production model—expected to deliver significant performance improvements, including higher silk yields, increased colony resilience, and reduced overall production costs. 'As we prepare to implement double hybrid crosses into our production platform, we are opening the door to greater scalability, efficiency, and product consistency,' Thompson continued. 'This is a key step forward in our mission to bring the power of spider silk to mainstream markets.' The Company is continuing its focus on building a robust and scalable production system as it transitions from pilot operations to full-scale manufacturing. For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit . For details about other recent Kraig Labs advancements, please watch the Company's investor conference at or on the Company's YouTube Channel . To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to * For a description of our historical leadership in this technology, please follow this link About Kraig Biocraft Laboratories, Inc. Kraig Biocraft Laboratories, Inc. ( ), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry. Cautionary Statement Regarding Forward Looking Information Statements in this press release about the Company's future and expectations other than historical facts are 'forward-looking statements.' These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as 'believes,' 'plans,' 'expects,' 'anticipates,' 'foresees,' 'estimated,' 'hopes,' 'if,' 'develops,' 'researching,' 'research,' 'pilot,' 'potential,' 'could' or other words or phrases of similar import. Forward-looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security. Ben Hansel, Hansel Capital, Inc. (720) 288-8495 [email protected]
Yahoo
28-05-2025
- Business
- Yahoo
Kraig Biocraft Laboratories Announces New Spider Silk Parental Strain for Expanded Commercial Production
Company Expands Capacity to Meet Material Demand and Scale Inventory by developing new parental Strain for Production ANN ARBOR, Mich., May 28, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, announces today the successful development of a new recombinant spider silk parental line, purpose-built for large-scale commercial production. This newly developed strain represents the third commercial production line created by Kraig Labs as it executes on its strategy to expand output capacity. The addition of this next-generation silk-producing line comes as the Company ramps up production to fulfill current material requests and strategically build inventory for future sales. "Our team continues to deliver on key milestones as we scale the commercialization of spider silk," said Company Founder and CEO, Kim Thompson. "With the development of this new production strain, we are not only increasing our ability to meet existing demand, but also reinforcing the foundation for our future growth. This new strain is part of the production roadmap we outlined in 2024 and a key part of our transition to a full double hybrid production system." This latest strain is part of Kraig Labs' broader development pipeline, which includes several additional parental lines currently in advanced stages of development. These lines are designed to enable a transition to a double hybrid production model—expected to deliver significant performance improvements, including higher silk yields, increased colony resilience, and reduced overall production costs. "As we prepare to implement double hybrid crosses into our production platform, we are opening the door to greater scalability, efficiency, and product consistency," Thompson continued. "This is a key step forward in our mission to bring the power of spider silk to mainstream markets." The Company is continuing its focus on building a robust and scalable production system as it transitions from pilot operations to full-scale manufacturing. For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit For details about other recent Kraig Labs advancements, please watch the Company's investor conference at or on the Company's YouTube Channel To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to * For a description of our historical leadership in this technology, please follow this link About Kraig Biocraft Laboratories, Inc. Kraig Biocraft Laboratories, Inc. ( a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry. Cautionary Statement Regarding Forward Looking Information Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward-looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security. Ben Hansel, Hansel Capital, Inc.(720) 288-8495ir@ in to access your portfolio
Yahoo
15-05-2025
- Business
- Yahoo
Kraig Biocraft Laboratories Receives Business License to Begin Operations in Cambodia
New Location to Support Unprecedented 2025 Spider Silk Production Expansion ANN ARBOR, Mich., May 15, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ('Company' or 'Kraig Labs'), a world leader in spider silk technology*, announces today that it has officially received its business license to begin operations in the Kingdom of Cambodia. This milestone marks a significant step in the Company's ongoing strategy to scale up and diversify its production capabilities in response to the exceptional success of its 2025 expansion initiatives. The Company's decision to launch operations in Cambodia is grounded in the continued positive momentum Kraig Labs has achieved through its expanded production efforts this year. 'This license represents more than just geographic growth—it's a reflection of the strong foundation we've built through our 2025 production expansion,' said Jon Rice, COO of Kraig Labs. 'Cambodia offers the right combination of climate, infrastructure, and opportunity to support the next phase of our spider silk production scale up. We are confident that this new location will play a role in helping continue to grow and diversity our production based for our spider silk materials.' The Cambodian business license is expected to support the Company's goals of increasing production capacity, while simultaneously diversifying its production footprint. As Kraig Labs embarks on this next phase of its business plan, it continues to invest in both research and infrastructure to advance the performance and scalability of its proprietary recombinant spider silk technologies. Kraig Labs remains committed to strengthening its production pipeline and establishing a global footprint that supports the commercial roll-out of next-generation biomaterials. For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit For details about other recent Kraig Labs advancements, please watch the Company's investor conference at or on the Company's YouTube Channel To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to * For a description of our historical leadership in this technology, please follow this link About Kraig Biocraft Laboratories, Inc. Kraig Biocraft Laboratories, Inc. ( a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry. Cautionary Statement Regarding Forward Looking Information Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security. Ben Hansel, Hansel Capital, LLC(720) 288-8495ir@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
06-05-2025
- Business
- Yahoo
Kraig Biocraft Laboratories Successfully Completes March
Kraig Biocraft Laboratories Company Continues to Meet 2025 Scale-Up Targets ANN ARBOR, Mich., May 06, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), a world leader in spider silk technology*, announces that it has successfully completed its March/April spider silk production run and is currently well underway with its May production cycle. Kraig Labs Recombinant Spider Silk Cocoons This steady progress reflects the Company's continued execution against its 2025 production scale-up plan, which builds on the significant operational and technical advancements achieved throughout 2024. Spider silk production for March and April met internal performance benchmarks and production targets, reinforcing confidence in the expanded capacity and workflow improvements implemented earlier this year. With May's production already in progress, Kraig Labs is maintaining its momentum and remains on track to meet its full-year production capacity goals. These efforts support Kraig Labs' broader strategy to transition recombinant spider silk from pilot-scale production to commercial viability across multiple markets. "Our teams in Vietnam and the U.S. continue to demonstrate consistent execution and focus," said Company Founder and CEO, Kim Thompson. "With each completed cycle, we are strengthening our manufacturing capabilities and moving closer to our goal of delivering commercial volumes of eco-friendly, performance fiber." The Company will provide further updates as it progresses through its 2025 production calendar. For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit For details about other recent Kraig Labs advancements, please watch the Company's investor conference at or on the Company's YouTube Channel To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to * For a description of our historical leadership in this technology, please follow this link About Kraig Biocraft Laboratories, Inc. Kraig Biocraft Laboratories, Inc. ( ), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry. Cautionary Statement Regarding Forward Looking Information
Yahoo
12-03-2025
- Business
- Yahoo
24/7 Market News Reports that Kraig Biocraft Laboratories is Featured in Major Vietnamese News Outlet
Lam Dong, Vietnam--(Newsfile Corp. - March 12, 2025) - a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, reports that Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Kraig Labs") was featured in a Major Vietnamese news outlet, Lam Đồng. Non-budget capital investment projects have been creating a driving force for Lam Dong province to develop in many aspects. Photo: Huu Long To view an enhanced version of this graphic, please visit: Kraig Labs recently received a Vietnamese investment certificate and the Lam Đồng article can be found at For additional details covering this development, please go to Kraig Biocraft Laboratories Secures Investment Approval in Vietnam, Expanding Silk Fiber Operations by clicking here. Please click here to read the recently published Kraig Labs analyst report on Kraig Labs logo To view an enhanced version of this graphic, please visit: For details about other recent Kraig Labs advancements, please watch the Company's investor conference at or on the Company's YouTube Channel To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to BAM-1 silkworms from recent production run To view an enhanced version of this graphic, please visit: Contact sales@ for Analyst Report coverage and other investor/public relations services. About Kraig Biocraft Laboratories, Inc. Kraig Biocraft Laboratories, Inc. ( a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry. About 24/7 Market News 24/7 Market News is a leading platform for public company market news. As a pioneer in digital media, we are committed to the rapid dissemination of financial market news and information. We excel in creating innovative public relations campaigns to help our clients effectively reach their target audience. 24/7 Market News offers paid coverage for public companies. For more information or PR inquiries, please contact: sales@ Please go to for further information. 24/7 MARKET NEWS, INC DisclaimerPlease go to for disclaimer information. CONTACT:24/7 Market NewsEditor@ Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company's ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company's ability to continue as a going concern, the popularity and/or competitive success of the Company's acquired football and other sports teams, the Company's ability to attract players and staff for acquired clubs, unsuccessful acquisitions or other strategic transactions, the possibility of a decline in the popularity of football or other sports, the Company's ability to expand its fanbase, sponsors and commercial partners, general economic conditions, and other risk factors detailed in the Company's filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law. To view the source version of this press release, please visit Sign in to access your portfolio
